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PT 525 Clinical Medicine, Pharmacology and Exercise Prescription, 4 credits
Spring 2003
Syllabus for Clinical Medicine and Pharmacology, 3 credits
Clinical Medicine and Pharmacology (75%) Exercise Prescription (25%)
Class Schedule:
Monday 2:10-3:00 SB 113 Exercise Prescription – J. Laskin
Tuesday 10:10-12:00 SB 114 Clinical Medicine and Pharmacology – S. Fehrer
Thursday 10:10-12:00 SB 114 Clinical Medicine and Pharmacology – S. Fehrer
Instructor: Dr. Steve Fehrer
SB 107, 243-2429
sfehrer@selway.umt.edu

Required Textbooks:
Goodman and Synder. Differential Diagnosis in Physical Therapy, 3rd edition. Saunders
2000. (GS)
Goodman, Boissonnault, and Fuller. Pathology Implications for the Physical Therapist.
Saunders 2003. (GB)
Ciccone. Pharmacology in Rehabilitation 3rd edition. F.A. Davis 2002. (C)
The listed readings are for enhancement of student understanding and clarification of
material presented in class. The course examinations will be based on material contained
in the class presentations.
Grading:
Student performance evaluation will be based on two 50-point tests and a 50-point
comprehensive final exam. Grade distribution: A = 90-100%, B = 80-89%, C = 70-79%,
<70% requires retake of test or final exam.
Any evidence of cheating or plagiarism will result in failure of the course and possible
remand to Academic Court for possible suspension or expulsion.
Schedule:
Tue 1/28

Thur 1/30

Immune – GS 390-433, GB 153-193, C 226-246
1. Review of immune physiology, aging and the immune system,
exercise immunology
2. Adult and juvenile rheumatoid arthritis, pathogenesis, clinical
manifestations, medical management
Immune
1. RA continued, pharmacologic agents (NSAIDs,
Glucocorticoids, DMARDs), PT management
2. HIV/AIDS, clinical manifestations, medical and PT management;
Chronic fatigue syndrome

Tue 2/4

Immune
1. Hypersensitivity disorders
2. Autoimmune diseases, systemic lupus erythematosus, fibromyalgia

Thur 2/6

Immune/Transplantation
1. Scleroderma, Guillain-Barre syndrome, differential diagnosis
2. Transplantation types, post-transplant complications, exercise

Tue 2/11

Transplantation – GB 772-820, C 633-649.
1. Considerations based on type, HSCT, kidney, liver, heart, lung
2. Immunomodulatory drugs

Thur 2/13

No class

Tue 2/18

Oncology – GS 334-389, GB 236-263, C 610-632.
1. Classification of neoplasm, aging, metastases
2. Medical management, exercise management

Thur 2/20

10:10- Noon Oncology
1. Cancer chemotherapy
2. PT monitoring of the client with cancer

Thur 2/20

1:10 – 3:00 Oncology
1. Differential diagnosis considerations for various cancers
2. Catch up

Tue 2/25

Integumentary – GB 264-316
1. Skin disease, aging, common skin disorders
2. Common skin disorders, Herpes zoster, pressure ulcers

Thur 2/27

Test 1; Integumentary
1. Test 1
2. Malignant neoplasms

Tue 3/4

Integumentary; Endocrine
1. Polymyositis and dermatomyositis, cold injuries, burns
2. Endocrine pathology, aging, adrenal malfunction

Thur 3/6

Endocrine – GS 287-333, GB317-366, C 433-529.
1. Thyroid malfunction, parathyroid malfunction
2. Diabetes Type 1 and 2, clinical manifestations

Tue 3/11

Endocrine
1. Medical management, pharmacological management
2. PT management of diabetes

Thur 3/13

Endocrine
1. Endocrine control of calcium homeostasis
2. Hormonal contraception, androgen abuse

Tue 3/18

Lymphatic – GB 477-508
1. Lymphatic physiology, lymphedema
2. Pathogenesis, clinical manifestations

Thur 3/20

Lymphatic
1. PT management
2. Lipedema

3/24-3/28 Spring Break
Tue 4/1

Hematology – GS 181-196, GB 509-552, C 373-385, 388-391.
1. Anemia, blood transfusion
2. Neoplasm of blood cells

Thur 4/3

Hematology
1. Thrombocytopenia, sickle cell disease, hemophilia
2. Thrombolytic drugs, antithrombotic drugs

Tue 4/8

GI – GS 197-233, GB 628-703, C 386-388.
1. Signs/symptoms disease, hernia, GERD, peptic ulcer disease
2. Inflammatory bowel syndrome, adenocarcinoma

Thur 4/10

Test 2; GI
1. Test 2
2. Appendicitis, peritonitis

Tue 4/15

GI
1. Hepatitis A B C, cholelithiasis
2. Alcoholic liver disease/cirrhosis, pancreatitis

Thur 4/17

GI
1. Pancreatic cancer, differential diagnosis
2. GI drugs – antiemetics, control gastric acidity, treat hyperlipidemia

Tue 4/22

Renal – GS 234-259, GB 704-728
1. Aging, urinary tract infections, chronic renal failure
2. Chronic renal failure, renal dialysis

Thur 4/24

Renal
1. Renal calculi, urinary incontinence
2. Differential diagnosis

Tue 4/29

Infectious disease – GB 194-235, C 537-589.
1. Signs/symptoms of infectious diseases, MRSA, isolation
2. Nosocomial infections, pneumococcal infections

Thur 5/1

Infectious disease
1. Tuberculosis, lyme disease
2. Antibacterial/antiviral drugs

Tue 5/4

Pharmacology – C 110-122, 142-166.
Anti-epileptics, anesthetics

Thur 5/6

Review: GS 434-508
Systemic origin of musculoskeletal pain

Final exam Monday May 12 8:00-10:00
Course Objectives:
1=Knowledge
2=Application
3=Psychomotor
4=Analysis, Synthesis, and Evaluation
5=Affective
A. Clinical decision Making and Examination
1.1 Describe the process of hypothesis oriented algorithms within the context of the Nagi model of
disability as it is used to guide physical therapy diagnosis, evaluation, and treatment.
1.2 Differentiate between disease and illness, signs and symptoms, acute and chronic illness.
1.3 Define differential diagnosis and state the role it plays in physical therapy practice.
1.4 Describe the sources and types of pain.
2.1 Recognize constitutional symptoms of systemic disease and utilize them in the completion of
differential diagnosis.
4.1 Engage in diagnostic process to establish differential diagnosis for patients across the lifespan based on
evaluation of examination results and medical and psychological information.
4.2 Determine the need for further examination or consultation by a physical therapist or for referral to
another health care professional.
B. Interviewing the patient
1.1 Describe the appropriate interview process for patients receiving physical therapy.
4.1 Using case studies and written examination, determine the appropriate interview questions and analyze
resultant information for key indicators.
4.2 Using case studies and written examination, determine from interview data when referral to other health
care professionals is appropriate.
C.
1.1
1.2
1.3
1.4
1.5
1.6

Oncology
Describe the common presenting symptoms of persons with the common forms of cancer.
Describe the underlying pathology and theoretical causes of the common forms of cancer.
Describe the course of progression of the common forms of cancer.
Describe the typical patterns of medical management for clients with cancer.
Describe lifestyle risk factors for the prevention of cancer.
Describe the various chemotherapeutic agents and radiation therapy approaches used to manage
cancer.

4.1 Determine the impact of common medical management for cancer on physical therapy intervention for
this client population.
4.2 Using the typical referred pain patterns to determine if a client being seen for a possible
neuromusculoskeletal problem should be referred to another health care professional.
D.
1.1
1.2
1.3

Immunological diseases
Describe the common signs and symptoms of persons with various immunological disease states.
Describe the epidemiology, diagnosis and prognosis for rheumatoid arthritis and osteoarthritis.
Describe the appropriate physical therapy management of these clients, considering pain reduction,
deformity prevention, exercise prescription, and function preservation.
1.4 Describe the major differences between osteo- and rheumatoid arthritis.
1.5 Describe the medications commonly utilized to manage arthritis.
1.6 Describe the common forms of medical intervention for these disorders.
1.7 Describe the underlying pathology and theoretical causes.
1.8 Describe lifestyle risk factors for acquiring AIDS.
4.1 Using a case study, determine the type of immunological condition and appropriate physical therapy
intervention.
E. Endocrine disorders
1.1 Describe the common signs/symptoms of persons with endocrine disorders.
1.2 Describe the common forms of medical intervention for these disorders.
1.3 Describe the underlying pathologies for diabetes mellitus.
1.4 Describe the lifestyle risk factors for the prevention of type II diabetes.
1.5 Describe the pharmacological interventions commonly used to manage diabetes.
3.1 Demonstrate how to test blood glucose.
4.1 Determine the implications of medical management on physical therapy interventions.
F.
1.1
1.2
2.1
2.2
4.1

Integumentary disorders
Describe the common signs/symptoms of persons with these disorders.
Describe the common forms of medical intervention for these disorders.
Demonstrate how to monitor a client’s skin to assess for presence of skin cancer.
Demonstrate how to monitor a client’s skin to assess for presence of pressure ulcers.
Determine the implications of medical management on physical therapy interventions.

G. Gastrointestinal and urinary tract disorders
1.1 Describe the common signs/symptoms of persons with these disorders.
1.2 Describe the common forms of medical intervention for these disorders.
1.3 Describe the underlying pathologies for these disorders.
1.4 Describe the referred pain patterns for these disorders.
2.1 Explain how the clinician protects self from hepatitis infection.
4.1 Determine the implications of medical management on physical therapy interventions.
H.
1.1
1.2
1.3
4.1

Hematology and lymphatic disorders
Describe the common signs/symptoms of persons with these disorders.
Describe the common forms of medical intervention for these disorders.
Describe the medications used to alter blood clotting.
Determine the implications of medical management on physical therapy interventions.

I.
1.1
1.2
4.1

Transplantation
Describe the common transplantation procedures.
Describe the potential complications that a transplant patient may encounter.
Determine the implications of medical management on physical therapy interventions.

J. Infectious disease disorders
1.1 Describe the common signs/symptoms of persons with theses disorders.
1.2 Describe the common forms of medical intervention for these disorders.

1.3 Describe the medications used to treat these disorders.
1.4 Explain role of physical therapy in the delivery of services with clients in isolation.
1.5 Describe the PPD test and the significance of a positive result.
1.6 Explain how a therapist protects him/herself from TB exposure.
4.1 Determine the implications of medical management on physical therapy interventions.
K. Pharmacology
1.1 Describe the normal mechanisms of drug absorption, distribution, metabolism and excretion for
prescription and over-the-counter drugs.
1.2 Describe how the processes described in 1.1 are altered by disease state and age.
1.3 Match common drug names to appropriate drug categories.
1.4 Describe common side effects of drug categories, especially those affecting physical therapy
interventions.
2.1 Explain why physical therapists cannot prescribe drugs and should not advise patients/clients to take a
particular drug.
2.2 Demonstrate how to effectively communicate with a physician about particular medication(s) your
client is taking.
4.1 Given a patient history, determine the effects of a drug regimen on physical therapy treatment.
4.2 Determine when signs/symptoms indicate the need for a referral to a pharmacist or physician.

